Ying Feng

Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

Sergei I. Grivennikov, Kepeng Wang, Daniel Mucida et al. · Nature · 2012 · 1.3K citations · Full text

Cytokine, Medicine, Immunology +9

p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes

Guido T. Bommer, Isabelle Gerin, Ying Feng et al. · Current Biology · 2007 · 1.1K citations · Full text

Microrna Detection, Small Rna, Tumor Suppressor +5

Proteomic Markers of DNA Repair and PI3K Pathway Activation Predict Response to the PARP Inhibitor BMN 673 in Small Cell Lung Cancer

Robert J. Cardnell, Ying Feng, Lixia Diao et al. · Clinical Cancer Research · 2013 · 178 citations · Full text

Discovery and Characterization of (8<i>S</i>,9<i>R</i>)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1<i>H</i>-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3<i>H</i>-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent

Bing Wang, Daniel I. Chu, Ying Feng et al. · Journal of Medicinal Chemistry · 2015 · 162 citations · Full text

Pharmaceutical Science, Pharmacotherapy, Heterocycle Chemistry +19

Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway.

Peng Li, Wanjiang Xue, Ying Feng et al. · PubMed · 2016 · 136 citations · Full text

Gastric Cancer Cells, Pathology, Cancer Biology +19